Prothena Plc (PRTA) financials

NASDAQ · Health Care

$8.47 -4.62% Close Oct 30, 2026 Live

Prothena Plc revenue and earnings by year

Prothena Plc's revenue was $9.68 million in the fiscal year to December 31, 2025, down 92.8% from the year before. Net income was -$244 million, -2520.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 27.9% a year on average.

RevenueNet income
-$200M$0$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue101359154201111281
Revenue growth-92.8%47.9%69.5%-73.1%23414.3%4.8%-14.8%-96.5%2508.4%—
Operating income-215-155-191-13272-113-86-159-155-160
Operating margin-2216.4%-114.4%-209.1%-244.1%35.9%-13216.2%-10527.9%-16634.0%-564.2%-15121.8%
Net income-244-122-147-11767-111-78-156-153-160
Net margin-2520.6%-90.5%-160.9%-217.0%33.4%-13029.8%-9542.6%-16297.9%-556.8%-15176.1%
Diluted EPS-$4.53-$2.27-$2.76-$2.47$1.38-$2.79-$1.95-$3.94-$4.06-$4.66
Free cash flow-164-150-137-10992-81-54-30-135-133

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PRTA in Markets.

See also: PRTA returns

No forecast, no recommendation. This page describes Prothena Plc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.